SGMO- Sangamo Therapeutics, Inc
Sangamo Therapeutics, Inc (SGMO) has 6 insiders with recent SEC Form 4 filings, including 0 buys and 13 sells. SGMO is classified in the Biotechnology industry within the Health Care sector.
Insider Ownership
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 1.90M | $325.9K | - | |
| Other | 696.7K | $119.8K | - | |
| VP | 647.4K | $111.3K | - | |
| VP | 328.7K | $56.5K | - | |
| Other | 235.3K | $40.5K | - |
Activity
Buys and sells only
Transactions
10 filings · page 8
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| May 11, 2015 | Wolff Henry Ward | Exec VP &CFO | Sale+OE | 12,000 | $13.25 | $158,949.40 | -2.9% | |
| May 5, 2015 | Ando Dale G | VP, Therapeutic Dev. &CMO | Sale+OE | 15,000 | $12.29 | $184,297.50 | -13.6% | |
| May 4, 2015 | Ringo William R | Director | Sale+OE | 3,000 | $12.98 | $38,927.40 | -78.9% | |
| May 1, 2015 | Gregory Philip D | SVP Of Research &CSO | Sale+OE | 15,000 | $12.62 | $189,370.50 | -11.4% | |
| Apr 15, 2015 | Lanphier Edward O II | President &CEO | Sale+OE | 25,000 | $15.33 | $383,260.00 | -9.6% | |
| Apr 10, 2015 | Wolff Henry Ward | Exec VP &CFO | Sale+OE | 12,000 | $15.31 | $183,770.82 | -1.9% | |
| Apr 6, 2015 | Ando Dale G | VP, Therapeutic Dev. &CMO | Sale+OE | 15,000 | $14.94 | $224,172.00 | -13.6% | |
| Apr 6, 2015 | Ringo William R | Director | Sale+OE | 2,200 | $14.95 | $32,881.20 | -73.3% | |
| Apr 1, 2015 | Gregory Philip D | SVP Of Research &CSO | Sale+OE | 15,000 | $15.15 | $227,191.50 | -11.4% | |
| Mar 19, 2015 | Wolff Henry Ward | Exec VP &CFO | Sale+OE | 10,000 | $18.00 | $180,000.00 | -4.7% |